Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,597 | -27,797 | -19,024 | -12,679 | -5,699 |
| Depreciation Amortization | 1 | 1 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 329 | -185 | -322 | -298 | 275 |
| Other Working Capital | -1,145 | 967 | -1,531 | -1,060 | -2,380 |
| Other Operating Activity | 387 | 2,309 | 1,847 | 1,141 | 58 |
| Operating Cash Flow | $-10,025 | $-24,705 | $-19,030 | $-12,896 | $-7,746 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,284 | -40,700 | -37,263 | -28,012 | N/A |
| PPE Investments | N/A | -16 | -13 | N/A | N/A |
| Investing Cash Flow | $-21,284 | $-40,716 | $-37,276 | $-28,012 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 84,774 | 84,774 | 84,774 | 80,000 |
| Other Financing Activity | 0 | -8,323 | -8,323 | -8,321 | -6,719 |
| Financing Cash Flow | $N/A | $76,451 | $76,451 | $76,453 | $73,281 |
| Beginning Cash Position | 66,346 | 55,316 | 55,316 | 55,316 | 55,316 |
| End Cash Position | 35,037 | 66,346 | 75,461 | 90,861 | 120,851 |
| Net Cash Flow | $-31,309 | $11,030 | $20,145 | $35,545 | $65,535 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,025 | -24,705 | -19,030 | -12,896 | -7,746 |
| Capital Expenditure | N/A | -16 | -13 | N/A | N/A |
| Free Cash Flow | -10,025 | -24,721 | -19,043 | -12,896 | -7,746 |